AIDS Seminar
Large Community Outbreak of HIV-1 infection Linked to Injection Drug Use of Oxymorphone - Indiana, 2015
Tuesday, September 12, 10:30-11:30am
Dita Broz, PhD, MPH - Centers for Disease Control and Prevention
NYU Meyers, 433 First Avenue, Room 760


New York Academy of Medicine
Nursing with a Message: Public Health Demonstration in New York City
Thursday, September 14, 6:00-7:30pm
NYAM, 1216 Fifth Avenue
Find more information at register for the event HERE.

ICAP Grand Rounds Webinar
Male Engagement in HIV Services
Tuesday, September 19, 9:00am
Ruanne Barnabas, DPhil, MSc & Monisha Sharma, MPH - Univ of Washington
Log-in for the webinar HERE.


Pharmacogenomics of Anti-Retroviral Therapy in People Who Inject Drugs (R01)
The purpose of this funding opportunity is to identify genetic and epigenetic factors that affect the recovery of the CD4+ T cells in response to anti-retroviral therapy in HIV infected people who inject drugs.

Ethical, Legal, and Social Implications (ELSI) of Genomics Research Project Grant Program - reissue
This FOA invites applications that propose to study the ethical, legal and social implications (ELSI) of human genome research. Applications may propose studies using either single or mixed methods.


Hair testing is a simple and non-invasive addition to studies for those seeking biological confirmation of use of fentanyl and other NPS opioids. Joey Palamar has colleagues in Italy who conduct hair testing analysis using UHPLC-MS/MS are looking to collaborate with people conducting studies on heroin-using populations. He's been using this service for three years on his studies. Please contact him via email at if you, or anyone you know, are overseeing heroin studies and might be interested in adding a hair testing component. Analyses are expensive, but since they want to validate their new testing methods, they can likely examine 50-100 hair samples free of charge. They can test for: fentanyl plus 15 new analogues, including carfentanyl and U-47700.


Carliner H, Brown QL, Sarvet AL, & Hasin DS (2017) Cannabis use, attitudes, and legal status in the US: a review. Preventive Medicine, doi: 10.1016/j.ypmed.2017.07.008. Find the abstract on the publisher's website HERE.

Des Jarlais DC (2017) Harm reduction in the USA: the research perspective and an archive to David Purchase. Harm Reduction Journal, 14, 51. Find the full, open access article on the publisher's website HERE.

Dunn Navarra AM, Gwadz MV, Whittemore R, Bakken SR, Cleland CM, Burleson W, Jacobs SK, & Melkus GD (2017) Health technology-enabled interventions for adherence support and retention in care among US HIV-infected adolescents and young adults: an integrative review. AIDS and Behavior, doi: 10.1007/s10461-017-1867-6. Find the abstract on the publisher's website HERE.

Palamar JJ, Acosta P, & Cleland CM (2017) Attitudes and beliefs about new psychoactive substance use among electronic dance music party attendees. Substance Use and Misuse, doi: 10.1080/10826084.2017.1327980. Find the abstract on the publisher's website HERE.


Third Annual Health Disparities Symposium
October 12 - New York, NY
The deadline for submitting abstracts has been extended through August 14
Register for the event HERE, submit an abstract HERE.

10th Annual Conference on the Science of Dissemination and Implementation in Health
A Decade of Progress and the Path Forward
December 4-6 - Arlington, VA

2018 Annual CUGH Global Health Conference
Health Disparities: A Time for Action
March 16-18, 2018 - New York, NY
Accepting abstracts through September 28